My child has Wilson disease. What should I tell their school?
Schools mostly need to know three things: that your child takes medication on time, that copper-rich foods should be avoided, and who to call in an emergency. A short letter from your hepatologist solves nearly all questions.
Children with well-controlled Wilson disease typically attend regular school, play sports, sit standardized exams, and live normal lives. The school’s role is supportive, not central.
Wilson disease can appear in children as young as three years old, though it most commonly comes to attention during the school years.1 In young children the first signs almost always involve the liver rather than the nervous system, so the diagnosis is usually made — and treatment started — before school-age neurological problems arise.2 Once treatment is established and copper levels are stable, the evidence consistently shows that children with Wilson disease develop normally and perform at school the same as their peers.3
What the school needs to know
A short letter from your child’s hepatologist is the most efficient tool. It should explain:
- The diagnosis, in plain language: “X has Wilson disease, a treatable inherited condition affecting copper metabolism.”
- Medication, including the timing if any doses are taken at school. Chelating agents (the copper-removing medicines) need to be taken on an empty stomach — typically at least 30 to 60 minutes before a meal — so lunchtime dosing has to be planned carefully.4
- Diet — a short list of foods to avoid in school cafeterias and at school events. The most copper-dense foods are shellfish, liver, nuts, chocolate, mushrooms, and nut butters.5 The goal is not a perfectly copper-free diet (that is impossible), but a practical reduction in the highest-copper sources.5
- Activity — the child can do all normal activities unless an individual circumstance changes that.
- Emergency contacts — your phone number and the hepatologist’s office.
Practical things to set up
- A medication plan with the school nurse
- A note in the cafeteria so high-copper foods can be substituted at school events (birthday parties, field trips)
- A teacher aware that the child may need to leave class briefly to take a dose
- For overnight school trips, a letter explaining the medication and the daily routine
Talking to the child
Children with Wilson disease can usually understand the basics by age 7–9: “Your body collects too much of a metal called copper, so we take a medicine that helps your body let go of it.” By age 10–12 they can usually take responsibility for the daily dose with parental supervision.6
Research on young people with chronic liver disease confirms that self-management skills develop gradually through adolescence and that family and clinical teams play a key role in structuring that handover.7 There is no fixed age at which a child “should” be fully independent with their medication — what matters is that the steps toward independence are taken deliberately and with support.
The most important message you can give a young patient: this is a manageable, lifelong condition, not a tragedy. Children whose families speak about Wilson disease matter-of-factly — neither hiding it nor catastrophizing it — tend to do best psychologically.8
Bullying and stigma
If your child is teased about pills, restricted foods, or doctor visits, escalate with the school. A child should never be made to feel ashamed of a disease they did not choose. Research on children with chronic liver conditions shows that psychosocial wellbeing is strongly influenced by how well families, schools, and clinical teams coordinate around the child — and that proactive support prevents many problems before they start.8
This post is for patient education only and does not replace medical advice from your child’s hepatologist or specialist team. Treatment decisions — including medication doses, dietary targets, and the timing of any changes — should always be made with your doctor.
References
-
Roberts, Eve A. “Update on the Diagnosis and Management of Wilson Disease.” Current Gastroenterology Reports 20, no. 12 (2018). https://doi.org/10.1007/s11894-018-0660-7. ↩
-
Czlonkowska, Anna, et al. “Wilson Disease.” Nature Reviews Disease Primers 4, no. 1 (2018). https://doi.org/10.1038/s41572-018-0024-5. ↩
-
Chanpong, Atchariya, and Anil Dhawan. “Long-Term Urinary Copper Excretion on Chelation Therapy in Children with Wilson Disease.” Journal of Pediatric Gastroenterology and Nutrition 72, no. 2 (2021): 210–215. https://doi.org/10.1097/mpg.0000000000002982. ↩
-
Schilsky, Michael L., Eve A. Roberts, Jeff M. Bronstein, Anil Dhawan, and James P. Hamilton. “A Multidisciplinary Approach to the Diagnosis and Management of Wilson Disease: 2022 Practice Guidance on Wilson Disease from the American Association for the Study of Liver Diseases.” Hepatology 82, no. 3 (2025): E41–E90. https://doi.org/10.1002/hep.32801. ↩
-
Teufel-Schäfer, Ulrike, Christine Forster, and Nikolaus Schaefer. “Low Copper Diet — A Therapeutic Option for Wilson Disease?” Children 9, no. 8 (2022): 1132. https://doi.org/10.3390/children9081132. ↩↩
-
Alkhouri, Naim, Regino P. Gonzalez-Peralta, and Valentina Medici. “Wilson Disease: A Summary of the Updated AASLD Practice Guidance.” Hepatology Communications 7, no. 6 (2023). https://doi.org/10.1097/hc9.0000000000000150. ↩
-
Day, Jemma, Anna Hames, Megan Earl, Anna Simpson, and Deepak Joshi. “Self-Management Skills in a UK Sample of Young People with Chronic Liver Disease.” Pediatric Transplantation 27, no. 8 (2023). https://doi.org/10.1111/petr.14614. ↩
-
Wellen, Brianna C. M., Henry C. Lin, and Jacklyn E. Stellway. “Psychosocial Considerations in Pediatric Autoimmune Liver Disease.” Clinical Liver Disease 20, no. 4 (2022): 124–129. https://doi.org/10.1002/cld.1238. ↩↩
This is patient education, not medical advice. Always consult your own clinical team about decisions for your care.